• Development and execution of initiatives involving multiple Omeros pipeline targets before the U.S. Government, including funding collaborations associated with COVID, Cancer, and addition within the Department of HHS, NIH, BARDA, and the White House.

Duration: November 15, 2012 to September 6, 2020

General Issues: Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Health Issues

Spending: about $2,560,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2012: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), White House Office, Centers For Medicare and Medicaid Services (CMS), Natl Economic Council (NEC), Vice President of the U.S., Office of the Vice President of the United States, Defense - Dept of (DOD), Defense - Dept of (DOD)